Natco Pharma

Natco Pharma says USFDA clears inspection of its chemical division unit in Chennai

The USFDA released a copy of the EIR to the establishment that was the subject of an FDA or FDA-contracted inspection when the agency determines the inspection to be closed

Natco Pharma Apr-Jun quarter net jumps 70% to Rs 47.65 cr

Its consolidated net sales were up 38.02 percent to Rs 297.71 crore during the period under review

Pharma battle: Indian Patent office and MNCs should resist from the confrontational policy

Drug MNCs especially from the US have had a problematic relationship with the Indian Patent office so much so that the US government has placed India in the list of patently unfriendly patent countries in the world

Natco Pharma, partner clear patent case with Gilead, others over Tamiflu

In March last year, USFDA had granted tentative approval to Natco for the generic oseltamivir phosphate capsules

Natco Pharma gains 4.5% after filing ANDA with USFDA

Natco Pharma has filed new product applications with the US health regulator for generic version of drugs used in the treatment of nervous system disease and cancer.

Gilead to challenge hepatitis C drug patent rejection

An order by deputy controller of patents and designs Hardev Karar has said Gilead, which sells the drug under the Sovaldi brand in the US, failed to prove that there were enhancement of therapeutic efficacy in the new discovery.

Rivals Cipla, Natco gain on Novartis drug patent rejection

Shares in Natco Pharma and Cipla gain after the Supreme Court dismissed Swiss drugmaker Novartis AG's petition seeking patent for its cancer drug Glivec.

BDR's compulsory licence bid for cancer drug rejected: What it means

In India, a month's dose of the drug costs about Rs 1 lakh. BDR had applied for the licence in March and said it would sell the drug for Rs 8,100 a month.

US pushing India to hike cancer drug price

Rea's testimony is only the most explicit example of the Obama administration's efforts to use intellectual property manoeuvring to inflate medical costs abroad.

Healthcare overhaul: Indians will now get free generic drugs

The initiative would overhaul a system where healthcare is often a luxury and private clinics account for four times as much spending as state hospitals, despite 40 percent of the people living below the poverty line, or $1.25 a day or less.